Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
Cardiovascular disease is a major cause of morbidity and mortality among people with type 2 diabetes mellitus. The peroxisome proliferator-activated receptor (PPAR) agonists have a significant role on glucose and fat metabolism. Thiazolidinediones (TZDs) are predominantly PPARγ agonists, and their p...
Saved in:
Main Authors: | Ahmad Aljada, Kshitij Ashwin Shah, Shaker A. Mousa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2009/460764 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
by: M. C. Thomas, et al.
Published: (2012-01-01) -
Enhanced Hepatocarcinogenicity Due to Agonists of Peroxisome Proliferator-Activated Receptors in Senescent Rats: Role of Peroxisome Proliferation, Cell Proliferation, and Apoptosis
by: Jihan Youssef, et al.
Published: (2002-01-01) -
Peroxisome Proliferator-Activated Receptors in Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2007-01-01) -
Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
by: Shinji Kume, et al.
Published: (2008-01-01) -
Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
by: Sander Kersten
Published: (2008-01-01)